Virology

FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. According to a study released on Tuesday, April 21, 2020, the malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in an analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers report. (AP Photo/John Locher)
April 21, 2020 - 3:49 pm
A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers reported. The nationwide study was not a...
Read More
Taiwan McCall, left, useless a nasal swab to test James Reese for COVID-19 in the Harlem section of New York, Monday, April 20, 2020. While many laboratories and companies are now offering tests, there are still only two main types available. The nasal swab test tells you if you have an active viral infection right now. A separate blood test tells you if you were previously exposed to the virus and fought off the infection. (AP Photo/Seth Wenig)
April 21, 2020 - 3:14 pm
WASHINGTON (AP) — Testing is critical to controlling the coronavirus and eventually easing restrictions that have halted daily life for most Americans. But there's been confusion about what kinds of tests are available and what they actually measure. There are still just two main types in the U.S...
Read More
President Donald Trump speaks during an event celebrating American truckers, at the White House, Thursday, April 16, 2020, in Washington. (AP Photo/Evan Vucci)
Associated Press
April 17, 2020 - 9:02 am
WASHINGTON (AP) — China is pushing back against President Donald Trump and some of his officials, who’ve flirted in recent days with an outlier theory that the coronavirus was set loose by a Chinese lab that let it escape. The Chinese Foreign Ministry spokesman on Friday accused the U.S...
Read More
A Thai family of four, wearing face masks travel in a motorbike in Bangkok, Thailand, Thursday, April 16, 2020. A month-long state of emergency remain enforced in Thailand to allow its government to impose stricter measures to control the coronavirus that has infected hundreds of people in the Southeast Asian country. (AP Photo/Gemunu Amarasinghe)
April 17, 2020 - 8:52 am
The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with existing health problems, it can cause more severe illness or death. TOP OF THE HOUR: — Putin warns Russia yet to see peak of virus...
Read More
FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. Announced Thursday, April 16, 2020, a U.S. study of a potential COVID-19 vaccine is being expanded to include older adults, the age group most at risk from the new virus. (AP Photo/Ted S. Warren)
April 16, 2020 - 4:01 pm
A U.S. study of a potential COVID-19 vaccine is being expanded to include older adults, the age group most at risk from the new coronavirus. The shot, made by the National Institutes of Health and Moderna Inc., is being tested in healthy young and middle-aged adults in Seattle and Atlanta. Moderna...
Read More
Patients and medical workers wear personal protective equipment due to COVID-19 concerns outside the emergency room at NYU Langone Medical Center, Monday, April 13, 2020, in New York. The new coronavirus causes mild or moderate symptoms for most people, but for some, especially older adults and people with existing health problems, it can cause more severe illness or death. (AP Photo/John Minchillo)
Associated Press
April 13, 2020 - 8:02 pm
WASHINGTON (AP) — New York's coronavirus death toll topped 10,000 and the worldwide number of confirmed cases hovered around 2 million on Monday, even as the lack of fresh hot spots globally yielded a ray of optimism and fueled discussions about how some places might begin to reopen. The brunt of...
Read More
FILE - In this Thursday, April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. Scientists in Brazil have stopped part of a study of the malaria drug touted as a possible coronavirus treatment after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested. Chloroquine and a similar drug, hydroxychloroquine, have been pushed by President Donald Trump after some early tests suggested the drugs might curb coronavirus entering cells. (AP Photo/Manish Swarup, File)
April 13, 2020 - 11:40 am
Scientists in Brazil have stopped part of a study of a malaria drug touted as a possible coronavirus treatment after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested. Chloroquine and a newer, similar drug called hydroxychloroquine, have been pushed...
Read More
This 2020 electron microscope image made available by the U.S. Centers for Disease Control and Prevention shows the spherical particles of the new coronavirus, colorized blue, from the first U.S. case of COVID-19. Antibody blood tests for the coronavirus could play a key role in deciding whether millions of Americans can safely return to work and school. But public health officials warn that the current “Wild West” of unregulated tests is creating confusion that could ultimately slow the path to recovery. (Hannah A. Bullock, Azaibi Tamin/CDC via AP)
April 12, 2020 - 11:06 am
WASHINGTON (AP) — Blood tests for the coronavirus could play a key role in deciding whether millions of Americans can safely return to work and school. But public health officials warn that the current “Wild West” of unregulated tests is creating confusion that could ultimately slow the path to...
Read More
In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a participant in a COVID-19 coronavirus vaccine trial receives an injection in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)
April 08, 2020 - 2:07 pm
WASHINGTON (AP) — U.S. researchers have opened another safety test of an experimental COVID-19 vaccine, this one using a skin-deep shot instead of the usual deeper jab. The pinch should feel like a simple skin test, a researcher told the volunteer lying on an exam table in Kansas City, Missouri, on...
Read More
In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
April 06, 2020 - 3:35 pm
The new coronavirus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit. When they offered him a chance to help test...
Read More

Pages